Guaifenesin and Dextromethorphan HBR
- Product NDC
- 51316-009
- 11-digit product format
- 513160009
- Labeler code
- 51316
- Product ID
- 51316-009_2885f0f5-e5ad-b667-c442-753a48d3f900
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin and Dextromethorphan HBR
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- CVS Pharmacy
- Application
- ANDA217340
- Marketing category
- ANDA
- Marketing start
- 2023-08-15
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 30; 600 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217340-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-01 | ||
| A217340-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A217340-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-01 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A217340-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-01 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Members Mark Mucus Relief DM | GUAIFENESIN AND DEXTROMETHORPHAN HBR | SAM'S WEST INC | 2b59f90b-b8fc-03c0-3527-a8efa97fbfe3 | 2025-11-30 | Warnings | 217340 ANDA217340 |
| Guaifenesin and Dextromethorphan HBR | GUAIFENESIN AND DEXTROMETHORPHAN HBR | Dr. Reddy's Laboratories Inc. | 5e95d8c0-d521-45b6-ccaf-7786fbd14d5c | 2025-11-30 | Warnings | 217340 ANDA217340 |
| Guaifenesin and Dextromethorphan HBR | GUAIFENESIN AND DEXTROMETHORPHAN HBR | CVS Pharmacy | 7942eeae-0528-4416-bd2f-b05acc71c0a9 | 2024-11-10 | Warnings | 217340 ANDA217340 51316-009 |
| Guaifenesin and Dextromethorphan HBR | GUAIFENESIN AND DEXTROMETHORPHAN HBR | Dr. Reddy's Laboratories Inc. | 49d7f70d-ff79-0708-3eda-efa5bf61da6c | 2024-03-19 | Warnings | 217340 ANDA217340 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin and Dextromethorphan HBR
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 30 mg/1 |
| DEXTROMETHORPHAN HYDROBROMIDE | 600 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
| 9D2RTI9KYH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1298324 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7942eeae-0528-4416-bd2f-b05acc71c0a9 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51316-009-01 | Guaifenesin and Dextromethorphan HBR | 20 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 20 | 4 | |
| 51316-009-01 | Guaifenesin and Dextromethorphan HBR | 5 in 1 CARTON | TABLET, EXTENDED RELEASE | 5 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1298324 | guaiFENesin 600 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet | PSN | 7942eeae-0528-4416-bd2f-b05acc71c0a9 | 4 |
| 1298324 | 12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Extended Release Oral Tablet | SCD | 7942eeae-0528-4416-bd2f-b05acc71c0a9 | 4 |
| 1298324 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG 12 HR Extended Release Oral Tablet | SY | 7942eeae-0528-4416-bd2f-b05acc71c0a9 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 51316-009-01 | 51316000901 | 5 BLISTER PACK in 1 CARTON (51316-009-01) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 5 blister pack | 2023-08-15 | No | No | Current |